ErinGuestMD

PubMed

• 24 citations
  Racial and ethnic disparities in childhood and young adult acute lymphocytic leukaemia: secondary analyses of eight Children's Oncology Group cohort trials.
  Sumit Gupta, Yunfeng Dai, Zhiguo Chen, Lena E Winestone, David T Teachey
  The Lancet. Haematology. 2023-02-01
• 21 citations
  Emergency medical genomes: a breakthrough application of precision medicine
  Stephen F. Kingsmore, Josh E Petrikin, Laurel K. Willig, Erin M. Guest
  Genome Medicine. 2015-07-30
• 19 citations
  Precision Medicine in Pediatric Cancer: Current Applications and Future Prospects
  Atif A. Ahmed, Divya S Vundamati, Midhat S. Farooqi, Erin M. Guest
  High-Throughput. 2018-12-13

Journal Articles

• Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemia  
  van Weelderen RE, Harrison CJ, Klein K, et al, Blood Adv, 6/25/2024
• Azacitidine as epigenetic priming for chemotherapy is safe and well-tolerated in infants with newly diagnosed KMT2A-rearranged acute lymphoblastic leukemia: Children's...  
  Guest EM, Kairalla JA, Devidas M, Haematologica, 6/13/2024
• Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood KMT2A-Rearranged Acute Myeloid Leukemia: A Study by the Int...  
  van Weelderen RE, Klein K, Harrison CJ, et al, J Clin Oncol, 6/1/2023
• Minimal residual disease predicts outcomes in KMT2A-rearranged but not KMT2A-germline infant acute lymphoblastic leukemia: Report from Children's Oncology Group study ...  
  Faulk KE, Kairalla JA, Dreyer ZE, et al, Pediatr Blood Cancer, 5/31/2023
• Racial and ethnic disparities in childhood and young adult acute lymphocytic leukaemia: secondary analyses of eight Children's Oncology Group cohort trials  
  Gupta S, Dai Y, Chen Z, et al, Lancet Hematol, 2/2023
• Preclinical efficacy of azacitidine and venetoclax for infant KMT2A-rearranged acute lymphoblastic leukemia reveals a new therapeutic strategy  
  Cheung LC, Aya-Bonilla C, Cruickshank MN, et al, Leukemia, 1/2023
• MicroRNA Content of Ewing Sarcoma Derived Extracellular Vesicles Leads to Biomarker Potential and Identification of a Previously Undocumented EWS-FLI1 Translocation  
  Crow J, Samuel G, Farrow E, et al, Biomark Insights, 10/31/2022
• Real-world use of tisagenlecleucel in infant acute lymphoblastic leukemia  
  Moskop A, Pommert L, Baggott C, et al, Blood Adv, 7/26/2022
• Outstanding outcomes in infants with KMT2A-germline acute lymphoblastic leukemia treated with chemotherapy alone: results of the Children's Oncology Group AALL0631 trial  
  Guest EM, Kairalla JA, Hilden JM, et al, Haematologica, 5/1/2022
• Single-cell multiomics reveals increased plasticity, resistant populations, and stem-cell-like blasts in KMT2A-rearranged leukemia  
  Chen C, Yu W, Alikarami F, et al, Blood, 4/7/2022
• Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric KMT2A-Rearranged AML: Results From the Phase III Children's Oncology Group Trial AA...  
  Pollard JA, Guest E, Alonzo TA, et al, J Clin Oncol, 10/1/2021
• Anaplastic Lymphoma Kinase Inhibitor in Treatment of Inflammatory Myofibroblastic Tumor of the Tongue in Infancy  
  Rao K, Farooki S, Guest E, et al, J Pediatr Hematol Oncol, 5/1/2021
• Overcoming Wnt-β-catenin dependent anticancer therapy resistance in leukaemia stem cells  
  Perry JM, Tao F, Roy A, Nat Cell Biol, 6/2020
• Decitabine and Vorinostat with Chemotherapy in Relapsed Pediatric Acute Lymphoblastic Leukemia: A TACL Pilot Study  
  Burke MJ, Kostadinov R, Sposto R, et al, Clin Cancer Res, 5/15/2020
• Treatment of children with relapsed and refractory acute lymphoblastic leukemia with mitoxantrone, vincristine, pegaspargase, dexamethasone, and bortezomib  
  August KJ, Guest EM, Lewing K, et al, Pediatr Blood Cancer, 3/2020
• Desensitization to pegaspargase in children with acute lymphoblastic leukemia and lymphoblastic lymphoma  
  August KJ, Farooki S, Fulbright JM, et al, Pediatr Blood Cancer, 1/2020
• Combined heparin/acid citrate dextrose solution A anticoagulation in the Optia continuous mononuclear cell protocol for pediatric lymphocyte apheresis  
  DeSimone RA, Myers GD, Guest EM, Shi PA, J Clin Apher, 8/2019
• Precision Medicine in Pediatric Cancer: Current Applications and Future Prospects  
  Ahmed AA, Vundamati DS, Farooqi MS, Guest E, High Throughput, 12/13/2018
• Gemtuzumab ozogamicin in infants with AML: results from the Children's Oncology Group trials AAML03P1 and AAML0531  
  Guest EM, Aplenc R, Sung L, et al, Blood, 8/17/2017
• Parental Perceptions of Obesity and Obesity Risk Associated With Childhood Acute Lymphoblastic Leukemia  
  Jones GL, McClellen W, Raman S, et al, J Pediatr Hematol Oncol, 7/2017
• Updates in the biology and therapy for infant acute lymphoblastic leukemia  
  Guest EM, Stam RW, Curr Opin Pediatr, 2/2017
• Emergency medical genomes: a breakthrough application of precision medicine  
  Kingsmore SF, Petrikin J, Willig LK, Guest E, Genome Med, 7/2015
• Childhood Cancer for the Primary Care Physician  
  Radhi M, Fulbright JM, Ginn K, Guest EM, Primary Care: Clinics in Office Practice, 1/1/2014
• Misleading Hepatitis B Testing in the Setting of Intravenous Immunoglobulin  
  Ilboudo CM, Guest EM, Ferguson AM, Garg U, Jackson MA, F1000Research, 1/2013
• An Unusual Case of Rapidly Progressive Hyperbilirubinemia  
  Thornton K, Nyp M, Music Aplenc L, Jones G, Carpenter S, Guest E, Shapiro S and Manimtim W, Case Reports in Pediatrics, 1/2013
• Join now to see all

Abstracts/Posters

• Lack of Parental Awareness of Obesity Risk in Survivors of Acute Lymphoblastic Leukemia in Childhood
  Jones G, Raman S, Sherman A, Guest E, August K, American Society of Pediatric Hematology & Oncology Annual Meeting, Chicago, IL, 1/1/2014
• Pneumocystis Jirovecii Pneumonia (PCP) in Children with Cancer: a Retrospective Cohort Analysis from the Pediatric Health Information System (PHIS) Database, 2004-2009
  Guest EM, Hall M, Shah S, August KJ, Fulbright JM, Goldman JL, Kalpatthi RV, Radhi MA, Gamis AS, American Society of Hematology Annual Meeting, San Francisco, CA, 1/1/2014
• Gemtuzumab Ozogamicin (GO) in Infants with Acute Myeloid Leukemia (AML) - Combined Results from the Children's Oncology Group (COG) Trials, AAML03P1 and AAML0531
  Guest EM, Aplenc R, Sung L, Raimondi SC, Hirsch BA, Alonzo TA, Gerbing RB, Wang YJ, Kahwash SB, and Heerema-McKenney A, Meshinchi S, and Gamis AS, American Society of Hematology Annual Meeting, San Francisco, CA, 1/1/2014
• Successful Liver Transplantation to Correct Severe Factor V Deficiency in a Child with Multiple Intracranial Hemorrhages
  Guest EM, Daniel JF, Andrews WS, and Wicklund BM, American Society of Pediatric Hematology & Oncology Annual Meeting, Montreal, Canada, 1/1/2010
• MLL Rearrangements in Acute Myeloid Leukemia: A Pilot Project to Expand and Study MLL-ENL in NOD Scid Gamma Mice
  Guest E and Shilatifard A, Children's Oncology Group Fall Meeting, Dallas, TX, 1/1/2010
• Hemoglobin Kansas City: a New Unstable Alpha Chain Variant Hemoglobin Associated with Low Systemic Arterial Saturation
  Guest EM, Neville KA, Hoyer JD, Safo MK, Garg U, Saunders C, Abdulmalik O, and Zwick D, American Society of Pediatric Hematology & Oncology Annual Meeting, San Diego, CA, 1/1/2009
• Challenges In The Presentation, Diagnosis And Treatments For Congenital Rhabdomyosarcoma Verses Fibromatosis Of The Tongue
  Kraft SM, Sykes KJ, Singh V, Manalang M, Guest E, Gamis A, Wei JL, Society for Ear, Nose and Throat Advances in Children Annual Meeting, Boston, MA, 1/1/2008
• Join now to see all

Lectures

• Single Cell Sequencing Reveals Heterogeneity of Gene Expression in KMT2A Rearranged Infant ALL at Relapse Compared to Diagnosis 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• International Society for Paediatric Oncology 
  Toronto, Canada - 1/1/2014
• Children's Oncology Group Pilot Study for Infant 
  Dallas, TX - 1/1/2013
• International Task Force on Infant 
  New Orleans, LA - 1/1/2013
• Join now to see all